Tracking the FDA precision oncology drug approval landscape in OncoKB Meeting Abstract


Authors: Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; Berger, M. F.; Syed, A.; Brannon, A. R.; Levine, R. L.; Dogan, A.; Drilon, A. E.; Solit, D. B.; Schultz, N.; Chakravarty, D.
Abstract Title: Tracking the FDA precision oncology drug approval landscape in OncoKB
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557403286
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.e13507
Notes: Meeting Abstract: e13507 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Solit
    781 Solit
  2. Marc Ladanyi
    1332 Ladanyi
  3. Ross Levine
    784 Levine
  4. Michael Forman Berger
    768 Berger
  5. Maria Eugenia Arcila
    669 Arcila
  6. Alexander Edward Drilon
    636 Drilon
  7. Nikolaus D Schultz
    491 Schultz
  8. Angela Rose Brannon
    99 Brannon
  9. Moriah Gabrielle Heller Nissan
    17 Nissan
  10. Aijazuddin Syed
    53 Syed
  11. Ahmet Dogan
    469 Dogan
  12. Ritika   Kundra
    89 Kundra
  13. Hongxin Zhang
    47 Zhang
  14. Calvin Lu
    5 Lu